MedicineAll countries · Checked
Wegovy Pill: Doses, Price and How It Compares With the Injection
The Wegovy pill is once-daily semaglutide for weight management. It starts at 1.5 mg and reaches the 25 mg maintenance dose on day 91. As of November 2026 it is approved in the US and the UK.
Tap a dose (mg)
Earliest you can start 1.5 mg
Day 1
What this dose isStarting dose
Time on this dose30 days
Next step up4 mg
From the US label. Your prescriber sets the pace.
Price depends on where you live.
See the price of the Wegovy pill and injection in the USIn the UK? See Wegovy price in the UK.
DoseHow to takeMissed doseVs injectionResultsSide effectsWho can take itCountriesPriceGenericFAQ
Wegovy pill dose
You start on 1.5 mg once a day. The dose goes to 4 mg on day 31, to 9 mg on day 61 and to 25 mg on day 91.
11.5 mgDays 1 to 30The starting dose.
24 mgDays 31 to 60First step up.
39 mgDays 61 to 90Second step up.
425 mgFrom day 91The maintenance dose.
25 mg once a day is the maintenance dose, and there is nothing higher. If a step is hard to tolerate, your prescriber can delay the next one.
If 25 mg is not tolerated, the US label suggests switching to the 1.7 mg weekly injection. The injection schedule is in the Wegovy dosing chart.
How to take the Wegovy pill
Take one tablet in the morning on an empty stomach, with plain water only, up to 4 ounces. No other drink.
Swallow it whole. Do not split, crush, chew or dissolve it, and never take more than one a day.
Wait at least 30 minutes before food, drinks or other pills.
Keep the tablets at 68 to 77°F (20 to 25°C) in the original bottle, dry and closed. Short trips between 59 and 86°F (15 to 30°C) are allowed.
Wegovy pill missed dose
If you miss a day, skip that tablet and take the next one the following day. Do not double up.
Wegovy pill vs injection
Both are semaglutide. The injection is weekly and can be taken with or without food. The pill is daily and has the empty-stomach rule.
Pill and injection side by side
How oftenPill daily, injection weekly
Usual maintenance dosePill 25 mg, injection 2.4 mg
Average weight loss in trialsPill 13.6% (64 weeks), injection 14.9% (68 weeks)
Food rulesPill: empty stomach, water only. Injection: none
The two trials enrolled different people for different lengths of time, so the numbers are not a head-to-head result.
If you take the 2.4 mg injection, the label lets you stop it and start the 25 mg pill one week later. Going the other way, you start the 2.4 mg injection the day after your last pill.
The injection is covered in Wegovy (semaglutide) and Wegovy injection sites.
Wegovy pill weight loss results
In a 64-week trial of 307 adults with obesity, or overweight plus a weight-related condition, the 25 mg pill cut body weight by 13.6% on average. Placebo cut it by 2.4%.
Placebo−2.4%25 mg pill−13.6%Lost 10% or more59.8%
Among people on the pill, 76.3% lost at least 5% of their weight, 47.0% lost at least 15% and 27.9% lost at least 20%. On placebo the shares were 31.3%, 5.5% and 3.1%.
These are trial averages, not a promise for any one person. Everyone in the trial also followed a reduced-calorie diet and more activity.
Wegovy pill side effects
The most common side effects are stomach and gut problems: nausea, diarrhea, vomiting, constipation and stomach pain. They show up most while the dose is going up.
In the pill trial, 6.9% of people stopped because of a side effect (5.9% on placebo). Stomach and gut problems caused 3.4% to stop (2% on placebo).
You cannot use Wegovy if you or a close relative have had medullary thyroid cancer or MEN 2. The US label carries a boxed warning on thyroid C-cell tumors, which were seen in rodents.
If you take levothyroxine, the label says the pill can raise how much of it your body absorbs. Tell your prescriber so your thyroid dose can be checked.
Who can take the Wegovy pill
Adults with a BMI of 30 or more, or 27 to under 30 with at least one weight-related condition, alongside diet and exercise. Check your number with the BMI calculator.
In the US the pill is also approved to lower the risk of heart attack, stroke and cardiovascular death in adults with heart disease and obesity or overweight.
It is not known whether the pill is safe and effective under age 18.
Where the Wegovy pill is approved
In the US, Novo Nordisk announced the approval on December 22, 2025. In the UK, the medicines regulator approved it on June 11, 2026, but it is not yet available on the NHS. Eligibility is in Wegovy on the NHS.
In the EU, the European Medicines Agency's committee recommended tablets in 1.5, 4, 9 and 25 mg strengths on May 21, 2026.
Approval and launch dates differ by country. Supply updates are in Wegovy stock and availability.
Wegovy pill price
Price depends on the country, the dose and your coverage. Pill and injection prices are in Wegovy cost in the US and Wegovy price in the UK.
Paying in the US?
See the Wegovy savings card and who can use itTo compare countries, read Wegovy price by country.
Generic Wegovy pill and similar pills
Whether a generic exists is answered in Wegovy generic name.
The same ingredient is sold as a type 2 diabetes tablet in Rybelsus, with its own 3, 7 and 14 mg doses. A different pill from Lilly is covered in Foundayo (orforglipron).
Wegovy pill FAQ
How often do you take the Wegovy pill?
Once a day, in the morning on an empty stomach.
What is the highest Wegovy pill dose?
25 mg a day, which is also the maintenance dose.
Can I take the Wegovy pill with coffee?
No. Only plain water, up to 4 ounces, is allowed. Drink coffee at least 30 minutes later.
Can I take the Wegovy pill and injection together?
No. The label does not recommend using it with another semaglutide product or any other GLP-1 medicine.
Can you take the Wegovy pill without diabetes?
Yes. Adults who meet the weight criteria can be prescribed it, and the main trial excluded people with type 2 diabetes.
Keep reading
This page follows the US label and regulator announcements and is updated when they change. See how we check our pages.
Update log
: First published.
Sources
FDA, Wegovy US prescribing information, injection and tablets (revised February 2026).
Novo Nordisk, FDA approves Wegovy pill (December 22, 2025).
MHRA, First GLP-1 tablet for weight loss approved in the UK (June 11, 2026).
European Medicines Agency, CHMP summary of opinion, Wegovy tablets (May 21, 2026).
GLP1 Note is an independent information site. Which medicine and dose suit you is for your prescriber to decide.